Proton-beam therapy for tumors of the CNS

References

• Slater JD. Clinical applications of proton radiation treatment at Loma Linda University: review of a fifteen-year experience. Technol. Cancer Res. Treat.5(2), 81–89 (2006).
   PubMed Web of Science ®Google Scholar
• Slater JM. Considerations in identifying optimal particles for radiation medicine. Technol. Cancer Res. Treat.5(2), 73–79 (2006).
   PubMedGoogle Scholar
• Slater JM. Selecting the optimal particle for radiation therapy. Technol. Cancer Res. Treat.6(4), 35–39 (2007).
   PubMedGoogle Scholar
• Bonnett DE. Current developments in proton therapy: a review. Phys. Med. Biol.38, 1371–1392 (1993).
   PubMed Web of Science ®Google Scholar
• Suit H, Goldberg S, Niemierko A et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol.42(8), 800–808 (2003).
   PubMed Web of Science ®Google Scholar
• Douw L, Klein M, Fagel, SS et al. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol.8(9), 810–818 (2009).
   PubMed Web of Science ®Google Scholar
• Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin. Oncol.31(5), 702–713 (2004).
   PubMed Web of Science ®Google Scholar
• Brown PD, Buckner JC, O’Fallon JR et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J. Clin. Oncol.21(13), 2519–2524 (2003).
   PubMed Web of Science ®Google Scholar
• Laack NN, Brown PD, Ivnik RJ et al. Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Center Cancer Treatment Group prospective study. Int. J. Radiat. Oncol. Biol. Phys.63(4), 1175–1183 (2005).
   PubMedGoogle Scholar
• Monje M. Cranial radiation therapy and damage to hippocampal neurogenesis. Dev. Disabil. Res. Rev.14(3), 238–242 (2008).
   PubMed Web of Science ®Google Scholar
• Monje ML, Vogel H, Masek M et al. Impaired human hipocampal neurogenesis after treatment for central nervous system malignancies. Ann. Neurol.62(5), 515–520 (2007).
   PubMed Web of Science ®Google Scholar
• Abayomi OK, Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol.41(4), 346–351 (2002).
   PubMed Web of Science ®Google Scholar
• Mizumatsu S, Monje ML, Morhardt DR et al. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res.63(14), 4021–4027 (2003).
   PubMed Web of Science ®Google Scholar
• Merchant TE, Hua CH, Shukla H et al. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr. Blood Cancer51(1), 110–117 (2008).
   PubMed Web of Science ®Google Scholar
• Palm A, Johansson KA. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Acta Oncol.46(4), 462–473 (2007).
   PubMed Web of Science ®Google Scholar
• Suit H, Goldberg S, Niemierko A et al. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat. Res.167(1), 12–42 (2007).
   PubMed Web of Science ®Google Scholar
• Miralbell R, Lomax A, Cella L et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int. J. Radiat. Oncol. Biol. Phys.54(3), 824–829 (2002).
   PubMed Web of Science ®Google Scholar
• Newhauser WD, Fontenot JD, Mahajan A et al. The risk of developing a second cancer after receiving craniospinal proton radiation. Phys. Med. Biol.54(8), 2277–2291 (2009).
   PubMed Web of Science ®Google Scholar
• Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Oncol. Biol. Phys.65(1), 1–7 (2006).
   PubMed Web of Science ®Google Scholar
• Gottschalk B. Neutron dose in scattered and scanned proton beams: in regard to Eric J. Hall (Int. J. Radiat. Oncol. Biol. Phys.65, 1–7, 2006). Int. J. Radiat. Oncol. Biol. Phys.66, 1594 (2006).
   PubMedGoogle Scholar
• Paganetti H, Bortfeld T, Delaney TF. Neutron dose in proton radiation therapy: In regard to Eric J. Hall (Int. J. Radiat. Oncol. Biol. Phys.65, 1–7, 2006). Int. J. Radiat. Oncol. Biol. Phys.66, 1594–1595 (2006).
   PubMedGoogle Scholar
• Jarlskog C, Lee C, Bolch WE et al. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms. Physics Med. Biol.53(3), 693 (2008).
   PubMed Web of Science ®Google Scholar
• Zacharatou-Jarlskog C, Lee C, Jiang H et al. Monte Carlo simulations using whole-body pediatric and adult phantoms as virtual patients to assess secondary organ doses in proton radiation therapy. Med. Phys.33(6), 2123 (2006).
   Google Scholar
• Wroe A, Rosenfeld A, Schulte R. Out-of-field dose equivalents delivered by proton therapy of prostate cancer. Med. Phys.34, 3449–3456 (2007).
   PubMedGoogle Scholar
• Wroe A, Clasie B, Kooy H. Out-of-field dose equivalents delivered by passively scattered therapeutic proton beams for clinically relevant field configurations. Int. J. Rad. Onc. Biol. Phys.73(1), 306–313 (2009).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J. Clin.58(2), 71–96 (2009).
   Google Scholar
• Amberger-Murphy V. Hypoxia helps glioma to fight therapy. Curr. Cancer Drug Targets9(3), 381–390 (2009).
   PubMedGoogle Scholar
• van den Bent MJ, Afra D, de Witte O et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council. Lancet366(9490), 985–990 (2005). Erratum in: Lancet367(9525), 1818 (2006).
   PubMed Web of Science ®Google Scholar
• Schomas DA, Laack NN, Rao RD et al. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol.11(4), 437–445 (2009).
   PubMed Web of Science ®Google Scholar
• Walker M, Green S, Byar D et al. Randomized comparisons of radiotherapy and nitrosurias for the treatment of malignant glioma after surgery. N. Engl. J. Med.303, 1323–1329 (1980).
   PubMed Web of Science ®Google Scholar
• Lee S, Fraass B, Herbort K et al. Patterns of failure following high dose 3-D conformal radiotherapy for high grade astrocytomas: a quantitative dosimetric study. Int. J. Radiat. Oncol. Biol. Phys.43, 79–88 (1999).
   PubMedGoogle Scholar
• Chan J, Lee, S, Benedick F et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J. Clin. Oncol.20(6), 1635–1642 (2002).
   PubMed Web of Science ®Google Scholar
• Fitzek M, Thornton A, Rabinov J et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a Phase II prospective trial. J. Neurosurg.91, 251–260 (1999).
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol.10(5), 459–466 (2009).
   PubMed Web of Science ®Google Scholar
• Mirimanoff R, Mason W, Van den Bent M et al. Is long-term survival in glioblastoma possible? Updated results of the EORTC/NCIC Phase III randomized trial on radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus RT alone. Int. J. Radiat. Oncol. Biol. Phys.69(3), S2–S2 (2007).
   Web of Science ®Google Scholar
• Glas M, Happold C, Rieger J et al. Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. Clin. Oncol.27(8), 1257–1261 (2009).
   Google Scholar
• Ronson BB, Schulte RW, Han KP et al. Fractionated proton beam irradiation of pituitary adenomas. Int. J. Radiat. Oncol. Biol. Phys.64(2), 425–434 (2006).
   PubMedGoogle Scholar
• Luu QT, Loredo LN, Archambeau JO et al. Fractionated proton radiation treatment for pediatric craniopharyngioma: Preliminary report. Cancer J.12, 155–159 (2006).
   PubMed Web of Science ®Google Scholar
• Fitzek MM, Linggood RM, Adams J et al. Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int. J. Radiat. Oncol. Biol. Phys.64(5), 1348–1354 (2006).
   PubMed Web of Science ®Google Scholar
• Winkfield KM, Linsenmeier C, Yock TI et al. Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.73(3), 716–721 (2009).
   PubMed Web of Science ®Google Scholar
• Munzenrider JE. Proton therapy for uveal melanomas and other eye lesions. Strahlenther. Onkol.175(S2), 68–73 (1999).
   PubMedGoogle Scholar
• Zografos L, Ducrey N, Beati D et al. Metastatic melanoma in the eye and orbit. Ophthalmology110(11), 2245–2256 (2003).
   PubMed Web of Science ®Google Scholar
• Egger E, Zografos L, Schalenbourg A. Eye retention after proton beam radiotherapy for uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys.55(4), 867–880 (2003).
   PubMed Web of Science ®Google Scholar
• Egger E, Schalenbourg A, Zografos L. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys.51(1), 138–147 (2001).
   PubMed Web of Science ®Google Scholar
• Purdy JA. Dose to normal tissue outside the radiation therapy patient’s treated volume: a review of different radiation therapy techniques. Health Phys.95(5), 666–676 (2008).
   PubMed Web of Science ®Google Scholar
• Fossati P, Ricardi U, Orecchia R. Pediatric medulloblastoma: toxicity of current treatment and potential role of proton therapy. Cancer Treat. Rev.35, 79–96 (2009).
   PubMed Web of Science ®Google Scholar
• Lin R, Hug E, Schaefer R et al. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int. J. Radiat. Oncol. Biol. Phys.48(4), 1219–1226 (2000).
   PubMed Web of Science ®Google Scholar
• Yu GE, Loredo LN, Yonemoto LT et al. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J.10(6), 386–390 (2004).
   PubMedGoogle Scholar
• Timmermann B, Lomax AJ, Nobile L et al. Novel technique of craniospinal axis proton therapy with the spot-scanning system: avoidance of patching multiple fields and optimized ventral dose distribution. Strahlenther. Onkol.183(12), 685–688 (2007).
   PubMed Web of Science ®Google Scholar
• Krejcarek SC, Grant, PE, Henson, JW et al. Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation. J. Radiat. Oncol. Biol. Phys.68(3), 646–649 (2007).
   PubMed Web of Science ®Google Scholar
• Rutz HP, Weber DC, Goitein G et al. Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcome in children and adolescents: initial experience at Paul Scherrer Institute. Int. J. Radiat. Oncol. Biol. Phys.71(1), 220–225 (2008).
   PubMed Web of Science ®Google Scholar
• MacDonald SM, Safai S, Trofimov A et al. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int. J. Radiat. Oncol. Biol. Phys.71(4), 979–986 (2008).
   PubMed Web of Science ®Google Scholar
• St Clair WH, Adams JA, Bues M et al. Advantage of protons compared to conventional x-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys.58(3), 727–734 (2004).
   PubMed Web of Science ®Google Scholar
• Jain KK. Future prospects for the cure of brain cancer. Technol. Cancer Res. Treat.5(3), 183–184 (2006).
   PubMed Web of Science ®Google Scholar
• Gridley DS, Miller GM, Luo X et al. Proton radiation and TNF-α/Bax gene therapy for orthotopic C6 brain tumor in Wistar rats. Technol. Cancer Res. Treat.3(2), 217–227 (2004).
   PubMed Web of Science ®Google Scholar
• Brisman JL, Cosgrove GR, Thornton AF et al. Hyperacute neuropathological findings after proton beam radiosurgery of the rat hippocampus. Neurosurgery56(6), 1330–1337 (2005).
   PubMedGoogle Scholar
• Mao XW, Crapo JD, Mekonnen T et al. Radioprotective effect of a metalloporphyrin compound in rat eye model. Curr. Eye Res.34, 62–72 (2009).
   PubMed Web of Science ®Google Scholar
• Gridley DS, Makinde AY, Luo X et al. Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model. Anticancer Res.27(5A), 3101–3109 (2007).
   PubMed Web of Science ®Google Scholar
• Makinde AY, Luo-Owen X, Rizvi A et al. Effect of a metalloprorphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation. Anticancer Res.29(1), 107–118 (2009).
   PubMedGoogle Scholar
• Ohnishi K, Ohnishi T. The biological effects of space radiation during long stays in space. Biol. Sci. Space18(4), 201–205 (2004).
   PubMedGoogle Scholar
• Kerschensteiner M, Meinl E, Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience158(3), 1122–1132 (2009).
   PubMed Web of Science ®Google Scholar
• Gridley DS, Rizvi A, Luo-Owen X et al. Variable hematopoietic responses to acute photons, protons and simulated solar particle event protons. In Vivo22, 159–169 (2008).
   PubMed Web of Science ®Google Scholar
• Gridley DS, Pecaut MJ, Rizvi A et al. Low-dose, low-dose-rate proton radiation modulates CD4+ T cell gene expression. Int. J. Radiat. Biol.85(3), 250–261 (2009).
   PubMed Web of Science ®Google Scholar
• Gridley DS, Coutrakon GB, Rizvi A et al. Low dose photons modify liver response to simulated solar particle event protons. Radiat. Res.169, 280–287 (2008).
   PubMed Web of Science ®Google Scholar
• Fan JB, Mascia AE, Hsi W-C et al. Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking. Med. Phys.35(11), 4945–4954 (2008).
   PubMedGoogle Scholar
• Oelfke U, Bortfeld T. Optimization of physical dose distributions with Hadron beams: comparing photon IMRT with IMPT. Technol. Cancer Res. Treat.2(5), 401–412 (2003).
   PubMedGoogle Scholar
• Widesott L, Pierelli A, Fiorino C et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int. J. Radiat. Oncol. Biol. Phys.72(2), 589–596 (2008).
   PubMed Web of Science ®Google Scholar
• Trofimov A, Bortfeld T. Optimization of beam parameters and treatment planning for intensity modulated proton therapy. Technol. Cancer Res. Treat.2(5), 437–444 (2003).
   PubMedGoogle Scholar
• Rutz HP, Weber DC, Sugahara S et al. Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int. J. Radiat. Oncol. Biol. Phys.67(2), 512–520 (2007).
   PubMed Web of Science ®Google Scholar
• Weber DC, Lomax AJ, Rutz HP et al. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother. Oncol.71, 251–258 (2004).
   PubMed Web of Science ®Google Scholar
• Weber DC, Rutz HP, Pedroni ES et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience. Int. J. Radiat. Oncol. Biol. Phys.63(2), 401–409 (2005).
   PubMed Web of Science ®Google Scholar
• Nieder C, Mehta MP, Jalali R. Combined radio- and chemotherapy of brain tumours in adult patients. Clin. Oncol. (R. Coll. Radiol.)21(7), 515–524 (2009).
   PubMed Web of Science ®Google Scholar
• Noda SE, El-Jawahri A, Patel D et al. Molecular advances of brain tumor in radiation oncology. Semin. Radiat. Oncol.19(3), 171–178 (2009).
   PubMed Web of Science ®Google Scholar
• Mercer RW, Tyler MA, Ulasov IV et al. Targeted therapies for malignant glioma: progress and potential. BioDrugs23(1), 25–35 (2009).
   PubMedGoogle Scholar
• Tu LC, Foltz G, Lin E et al. Targeting stem cells – clinical implications for cancer therapy. Curr. Stem Cell Res. Ther.4(2), 147–153 (2009).
   PubMedGoogle Scholar